4//SEC Filing
Smith Robin L 4
Accession 0000850261-20-000029
CIK 0000850261other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 1:58 PM ET
Size
5.0 KB
Accession
0000850261-20-000029
Insider Transaction Report
Form 4
Smith Robin L
Director
Transactions
- Purchase
Common Stock
2020-03-05$2.27/sh+40,000$90,896→ 60,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.145 to $2.42, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price.
Documents
Issuer
Sorrento Therapeutics, Inc.
CIK 0000850261
Entity typeother
Related Parties
1- filerCIK 0001365035
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 1:58 PM ET
- Size
- 5.0 KB